Non-alcoholic steatohepatitis: the therapeutic challenge of a global epidemic
(EN)
Allard, Johane
Mouzaki, Marialena
Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide. Nonalcoholicsteatohepatitis (NASH) reflects severe liver disease within the NAFLD spectrumand can progress to end-stage liver disease. Within this manuscript we review the availableevidence for the treatment of NASH as well as the newer therapeutic agents that are currentlybeing investigated.Keywords NASH, fatty liver, treatment, vitamin E, pioglitazoneAnn Gastroenterol 2012; 25 (2): 207-217
(EN)